RxDoctor Payments DataLook up a doctor →

Gautam Samadder, MD

Sleep Medicine · Columbus, OHNPI 1033231188

Payments from drug & device makers

$52,871in general payments, 2019–2025

Across 505 payments — averaging $104.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Jazz Pharmaceuticals Inc.$15K
  • Lilly USA, LLC$14K
  • Idorsia Pharmaceuticals US Inc$9K
  • Inspire Medical Systems, Inc.$5K
  • Harmony Biosciences LLC$5K
  • Avadel CNS Pharmaceuticals, LLC$2K
  • plus $3K from 23 others

What the payments were for

  • Consulting fees$3,3706%
  • Speaking & faculty fees$32,47061%
  • Travel & lodging$2,5275%
  • Food & beverage$14,10827%
  • Education$3961%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$52,871 in reported general payments places this provider in the 85th percentile of 94 sleep medicine providers in Ohio.

See all sleep medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$285,707
Medicare patients
500
Services billed
1,436

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XywavSodium,calcium,mag,pot Oxybate164$2,870,366
WakixPitolisant Hcl62$867,699
XyremSodium Oxybate18$380,100
Sodium Oxybate16$294,922
Breztri AerosphereBudesonide/Glycopyr/Formoterol21$14,482
Modafinil42$12,648
Armodafinil57$5,742
Roflumilast14$4,509
Zolpidem Tartrate ErZolpidem Tartrate41$1,843
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine23$1,270
Clonazepam122$923
Methylphenidate Hcl17$903
Albuterol Sulfate HfaAlbuterol Sulfate21$656
Zolpidem Tartrate332$636
Gabapentin26$405

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Harmony Biosciences LLCWakix$4,634$867,69962 claims
AstraZenecaBreztri Aerosphere$355$14,48221 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 94 sleep medicine providers in Ohio.

Other sleep medicine in Columbus

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →